Search - tctmd.com

Displaying 241 - 260 of 984

Sort: Relevancy | Date

News Daily News

New Data Support Tighter Air Pollution Standards to Reduce CV Events

L.A. McKeown

February 27, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Daily News

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

L.A. McKeown

December 29, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Michael O'Riordan

December 13, 2022

News Daily News

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

L.A. McKeown

December 08, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Daily News

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Caitlin E. Cox

November 09, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

Advertisement

New Data Support Tighter Air Pollution Standards to Reduce CV Events

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

The Biggest News of 2022: TCTMD’s Top 10

Hypertension and Heavy Coffee Consumption a Bad Combo, Study Finds

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Heart Risks Higher With Moderna vs Pfizer/BioNTech Shot, Direct Comparison Shows

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content